Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy CollPlant Biotechnologies stock in Canada | $16

Own CollPlant Biotechnologies shares in just a few minutes.

CollPlant Biotechnologies is a biotechnology business based in the US. CollPlant Biotechnologies stocks (CLGN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $21.75 – a decrease of 5.33% over the previous week. CollPlant Biotechnologies employs 52 staff and has a trailing 12-month revenue of around $19.9 million.

How to buy CollPlant Biotechnologies stock in Canada

  1. Choose a platform. If you're a beginner, our stock trading table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: CLGN in this case.
  5. Research CollPlant Biotechnologies stocks. The platform should provide the latest information available.
  6. Buy your CollPlant Biotechnologies stocks. It's that simple.

Is it a good time to buy CollPlant Biotechnologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

How has Coronavirus impacted CollPlant Biotechnologies's stock price?

Since the stock market crash in March caused by coronavirus, CollPlant Biotechnologies's stock price has had significant positive movement.

Its last market close was $16, which is 14.38% up on its pre-crash value of $13.6996 and 97.04% up on the lowest point reached during the March crash when the stocks fell as low as $8.12.

If you had bought $1,000 worth of CollPlant Biotechnologies stocks at the start of February 2020, those stocks would have been worth $774.97 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,493.92.

CollPlant Biotechnologies stock price

Use our graph to track the performance of CLGN stocks over time.

CollPlant Biotechnologies stocks at a glance

Information last updated 2021-09-18.
Latest market close$16
52-week range$6.185 - $24.26
50-day moving average $17.7026
200-day moving average $16.3601
Wall St. target price$23
PE ratio 33.3212
Dividend yield N/A (0%)
Earnings per share (TTM) $0.505

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available Asset Types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
OFFER
Wealthsimple Trade
Stocks, ETFs
$0
N/A
$0
Free
Get a $50 bonus when you open a Wealthsimple Trade account and deposit and trade at least $150.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
BMO InvestorLine
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$9.95
$9.95 + $1.25 per options contract
$0 if conditions met, otherwise $25/quarter
$0 - $9.95
Buy and sell a select group of Canada’s most popular ETFs without paying commissions.
An easy-to-use online trading platform with access to research, tools, and the option to access InvestorLine adviceDirect for additional professional support.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$4.99-$9.99
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$0
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$6.95
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95-$9.95
$9.95 + $1 per contract
$0
Free
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
OFFER
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Get up to 50 free trades. Be one of the first 100 new Qtrade clients to use the promo code 50FREETRADES and deposit a minimum of $10,000 (or top up to $15,000 to get $150 transfer fees waived). Valid until September 30, 2021.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.
loading

Compare up to 4 providers

Online stock trading

CollPlant Biotechnologies price performance over time

Historical closes compared with the last close of $16

1 week (2021-09-15) -5.83%
1 month (2021-08-20) -4.31%
3 months (2021-06-22) -22.37%
6 months (2021-03-22) 28.10%
1 year (2020-09-22) 94.53%
2 years (2019-09-19) 299.00%
3 years (2018-09-21) 213.73%

Is CollPlant Biotechnologies under- or over-valued?

Valuing CollPlant Biotechnologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CollPlant Biotechnologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

CollPlant Biotechnologies's P/E ratio

CollPlant Biotechnologies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, CollPlant Biotechnologies stocks trade at around 33x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stocks or simply that they're over-valued.

CollPlant Biotechnologies's EBITDA

CollPlant Biotechnologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$6.1 million.

The EBITDA is a measure of a CollPlant Biotechnologies's overall financial performance and is widely used to measure a its profitability.

CollPlant Biotechnologies financials

Revenue TTM USD$19.9 million
Operating margin TTM 27.11%
Gross profit TTM USD$3.1 million
Return on assets TTM 10.22%
Return on equity TTM 17.69%
Profit margin 24.55%
Book value $4.819
Market capitalisation USD$172.6 million

TTM: trailing 12 months

How to short and sell CollPlant Biotechnologies stocks

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "CLGN.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 13,120 CollPlant Biotechnologies stocks held short by investors – that's known as CollPlant Biotechnologies's "short interest". This figure is 25.1% down from 17,528 last month.

There are a few different ways that this level of interest in shorting CollPlant Biotechnologies stocks can be evaluated.

CollPlant Biotechnologies's "short interest ratio" (SIR)

CollPlant Biotechnologies's "short interest ratio" (SIR) is the quantity of CollPlant Biotechnologies stocks currently shorted divided by the average quantity of CollPlant Biotechnologies stocks traded daily (recently around 18742.857142857). CollPlant Biotechnologies's SIR currently stands at 0.7. In other words for every 100,000 CollPlant Biotechnologies stocks traded daily on the market, roughly 700 stocks are currently held short.

However CollPlant Biotechnologies's short interest can also be evaluated against the total number of CollPlant Biotechnologies stocks, or, against the total number of tradable CollPlant Biotechnologies stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CollPlant Biotechnologies's short interest could be expressed as 0% of the outstanding stocks (for every 100,000 CollPlant Biotechnologies stocks in existence, roughly 0 stocks are currently held short) or 0.0013% of the tradable stocks (for every 100,000 tradable CollPlant Biotechnologies stocks, roughly 1 stocks are currently held short).

Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against CollPlant Biotechnologies.

Find out more about how you can short CollPlant Biotechnologies stock.

CollPlant Biotechnologies stock dividends

We're not expecting CollPlant Biotechnologies to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.

Have CollPlant Biotechnologies stocks ever split?

CollPlant Biotechnologies stocks were split on a 2:3 basis on 21 November 2016. So if you had owned 3 shares the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your CollPlant Biotechnologies stocks – just the quantity. However, indirectly, the new 50% higher stock price could have impacted the market appetite for CollPlant Biotechnologies stocks which in turn could have impacted CollPlant Biotechnologies's stock price.

CollPlant Biotechnologies stock price volatility

Over the last 12 months, CollPlant Biotechnologies's stocks have ranged in value from as little as $6.185 up to $24.26. A popular way to gauge a stock's volatility is its "beta".

CLGN.US volatility(beta: 0.78)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while CollPlant Biotechnologies's is 0.7762. This would suggest that CollPlant Biotechnologies's stocks are less volatile than average (for this exchange).

CollPlant Biotechnologies overview

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler for treating wrinkles; 3D Bioprinted breast implants that are used for the regeneration of breast tissue; injectable implants to promote breast tissue regeneration; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has a co-development agreement with 3D Systems Corporation for a 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site